Medication leaflets

Active substance

Results for the substance ranibizumab

4 results

About this active substance


Ranibizumab is a medication used to treat eye conditions such as age-related macular degeneration (AMD) and diabetic macular edema.
It is a monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), reducing the formation of abnormal blood vessels in the retina.

Treatment with ranibizumab helps prevent vision loss and, in some cases, can improve vision.
The medication is administered through intravitreal injections, usually at regular intervals as recommended by the doctor.

Side effects may include eye irritation, increased intraocular pressure, and, rarely, eye infections.
Patients should be closely monitored to prevent complications and assess the effectiveness of the treatment.

It is important to follow all medical instructions and attend regular check-ups to maintain eye health.